Hello traders!
If you "Follow" us, you can always get new information quickly.
Please also click “Boost”.
Have a good day.
-------------------------------------
(BNGO 1M chart)
It is renewing its low point by falling below the HA-Low indicator point of 6.49.
Touching the HA-Low indicator point means that there is a high possibility of forming a low point.
A...
Bionano
Short Term - We look to Sell at 1.78 (stop at 2.04)
Preferred trade is to sell into rallies. The trend of lower highs is located at 1.85. Our outlook is bearish. We have a 38.2% Fibonacci pullback level of 1.80 from 2.84 to 1.18. Bespoke resistance is located at 1.85.
Our profit targets will be 1.18 and 1.01
Resistance: 1.85 / 2.50 /...
Bionano Genomics - Short Term - We look to Buy a break of 2.52 (stop at 2.25)
A break of yesterdays high would confirm bullish momentum. Posted a Double Bottom formation. The measured move target is 3.36. We look for gains to be extended today.
Our profit targets will be 3.13 and 3.30
Resistance: 2.50 / 3.00 / 4.00
Support: 2.00 / 1.70 / 1.50
Disclaimer –...
The Motly Fool just came out with a nice article on this stock
The Motley Fool noted that Bionano Genomics’ non-sequencing-based optical mapping technology known as the Saphyr System was designed to rapidly characterize extremely long strands of genomic DNA. And the company recently acquired leading genomics data analysis software company BioDiscovery. This...
Bionano Genomics, it is in the field of gene sequencing.
The company`s product, Saphyr, uses optical genome mapping to help detect structural variations in gene sequencing.
Bionano recently acquired BioDiscovery for $100 million, which is a leader in clinical software production.
The acquisition may facilitate adoption of the Saphyr system, in $4 billion...
Hey everyone,
I hope you are doing fantastic!
$BNGO has presented us with an amazing set-up inside a channel.
We are currently sitting at the bottom of it and we have 2 TP ($8 and $10)
An amazing Risk-Reward with SL just above the channel.
I wish you all happy trading!
BNGO: everything above 4.29 is bullish. GAP fill is still possible. Trading below 5.35 --> focus on gap fill. Trading above 5.60 --> Target 6 USD. 5.50 is our new support & a possible bounce zone. Very hard to give exact price targets in the daily trading of small caps with low volume. Therefore I only give fewer updates for BNGO. Otherwise it could confuse some people;)
The short volume ratio is decreasing which means good news for us. - Fintel
Also looks like it's time for a reversal on the 1HR MACD so we could be in for a breakout with a high upside. All I'm hearing is nothing but good news associated with Bionano Genomics.
However, we cannot fail to ignore the declining revenues every year. Keep an eye on this till the next...
I have the feeling that Bionano Genomics ($BNGO) is not bullish on the daily timeframe. We can see less volume and the MACD is about to cross down.
But everything is possible! A great news ($ARK buying shares) can overturn the current market situation...
What's your opinion on this? Your comments are welcome.
##############
Take into account that fundamentals...
Based on Fundamental and Technical Analysis, the idea is to go long.
Bionano's symposium focused on the ability of its Saphyr optical genome mapping (OGM) system to analyze the genomes of people with diseases resulting from so-called genomic repeats, or repetitive sequences that can alter the function of genes.
NASDAQ:BNGO
$BNGO can go ahead and hit $10 real quick.
Your comments are welcome.
##############
Legal disclaimer: I am not a financial advisor. The advice here given is not a financial advice even though my excitement might make it look like such. This account shouldn't be followed by anyone expecting something from me. You trade at your own risk and nobody can guarantee...
BioNano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space.
Net Income $-29,820,000.00
Market Cap $69.23 million
Annual Sales $10.13 million
BNGO exceeded EARNINGS ESTIMATES in Q1 and on 7/17/2020 Maxim Group Reiterated the Rating to Buy and a target of $2.00 per share.
If you are interested to test some amazing buy...
